Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
about
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugsClassical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical rolesDifferential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in miceHuman hallucinogen research: guidelines for safetyMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens.Drug treatment of obsessive-compulsive disorderAntidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsIllegal drugs laws: clearing a 50-year-old obstacle to researchPsychedelicsPharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine].The effect of psilocin on memory acquisition, retrieval, and consolidation in the ratThe emerging role of meditation in addressing psychiatric illness, with a focus on substance use disordersSynthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.Clinical applications of hallucinogens: A review.Acute Effects of the Novel Psychoactive Drug 2C-B on EmotionsPerspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.Potential Therapeutic Effects of Psilocybin.Mind-altering drugs and research: from presumptive prejudice to a Neuroscientific Enlightenment?: Science & Society series on "Drugs and Science"Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD.Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.Unifying Theories of Psychedelic Drug Effects.
P2860
Q21129387-0A29E9B6-9A6C-4BA3-B497-5D8AC8AC2831Q22241778-136C7A33-21C6-4B0A-804D-8BBA031B9A29Q24594834-E3D34DB6-38FE-4A44-898D-BB39E359BDD7Q24600704-FA243E0C-BDF9-4436-9B5D-BF78BD410E40Q24620764-BACE7B3E-9FFD-41EA-9C45-77482583EAE8Q24635508-1934C440-B35D-4855-96A2-233CB001CA8BQ26746137-5D5512F1-4C66-427A-B056-473F2A691271Q28543098-0AB708B5-2D01-44BD-8A70-79DF066FA3B9Q30359998-DEB3463E-05CE-474C-8622-F4BF11DFE001Q30544127-45120AD7-C1F8-4303-AD00-4031FB64EE84Q33658155-78A72508-E31A-49D3-936E-7D850B2949DFQ34018674-E45F8BB4-2845-4377-AA7A-B5014E411574Q34396223-3C80FC02-45E0-4FEC-82BC-917E1B73B707Q34535259-D1E9F130-D85B-4C64-9DC8-737DB21D313AQ34674320-5BB94CC9-9DE7-43E1-9F3C-24F04F5FA008Q37113859-DB318FD1-21D5-45C5-B759-334345B5398CQ38690821-0A783B8C-2248-4606-9A29-BEC52B8E9707Q38741517-1AB1C110-44DD-45C2-863A-8248656395D7Q38798504-78071805-141D-4C15-A4DC-66A0456C8E97Q39414464-B19F6B19-1A1E-454D-A5B7-4B5C5544EA21Q42377130-86147BBE-7699-4C14-BFE0-A51F6D10E361Q47134467-B8DBBD17-BFDA-4FD6-9863-48957A34FA22Q47577495-5762E79C-AD4B-465F-A043-CE74C95382EFQ47654338-C3D2B32D-7C2C-4791-A279-262EB4E3CD3DQ52316527-107E80E0-CEE0-452E-BBC0-6A6518FC90B2Q52641641-2992E8D0-43AA-45E0-A64E-477EA517383D
P2860
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Safety, tolerability, and effi ...... obsessive-compulsive disorder.
@ast
Safety, tolerability, and effi ...... obsessive-compulsive disorder.
@en
Safety, tolerability, and effi ...... obsessive-compulsive disorder.
@nl
type
label
Safety, tolerability, and effi ...... obsessive-compulsive disorder.
@ast
Safety, tolerability, and effi ...... obsessive-compulsive disorder.
@en
Safety, tolerability, and effi ...... obsessive-compulsive disorder.
@nl
prefLabel
Safety, tolerability, and effi ...... obsessive-compulsive disorder.
@ast
Safety, tolerability, and effi ...... obsessive-compulsive disorder.
@en
Safety, tolerability, and effi ...... obsessive-compulsive disorder.
@nl
P2093
P356
P1476
Safety, tolerability, and effi ...... obsessive-compulsive disorder
@en
P2093
Christopher B Wiegand
E Keolani Taitano
Francisco A Moreno
Pedro L Delgado
P304
P356
10.4088/JCP.V67N1110
P577
2006-11-01T00:00:00Z